Neuroprotective effect of grape seed extract on brain ischemia: a proteomic approach.


Journal

Metabolic brain disease
ISSN: 1573-7365
Titre abrégé: Metab Brain Dis
Pays: United States
ID NLM: 8610370

Informations de publication

Date de publication:
06 2019
Historique:
received: 29 10 2018
accepted: 04 02 2019
pubmed: 24 2 2019
medline: 12 5 2020
entrez: 24 2 2019
Statut: ppublish

Résumé

Stroke is one of the leading causes of long-lasting disability in human and oxidative stress an important underlying cause. Molecular insights into pathophysiology of ischemic stroke are still obscure, and the present study investigated the protective effect of high dosage Grape Seed Extract (GSE 2.5 g/kg) on brain ischemia-reperfusion (I/R) injury using a proteomic approach. Ischemia was realized by occlusion of the common carotid arteries for 30 min followed by 1 h reperfusion on control or GSE pre-treated rats, and a label-free quantification followed by mass spectrometry analysis used to evaluate I/R induced alterations in protein abundance and metabolic pathways as well as the protection afforded by GSE. I/R-induced whole brain ionogram dyshomeostasis, ultrastructural alterations, as well as inflammation into hippocampal dentate gyrus area, which were evaluated using ICP-OES, transmission electron microscopy and immuno-histochemistry respectively. I/R altered the whole brain proteome abundance among which 108 proteins were significantly modified (35 up and 73 down-regulated proteins). Eighty-four proteins were protected upon GSE treatment among which 27 were up and 57 down-regulated proteins, suggesting a potent protective effect of GSE close to 78%of the disturbed proteome. Furthermore, GSE efficiently prevented the brain from I/R-induced ion dyshomeostasis, ultrastructural alterations, inflammatory biomarkers as CD56 or CD68 and calcium burst within the hippocampus. To conclude, a potent protective effect of GSE on brain ischemia is evidenced and clinical trials using high dosage GSE should be envisaged on people at high risk for stroke.

Identifiants

pubmed: 30796716
doi: 10.1007/s11011-019-00396-2
pii: 10.1007/s11011-019-00396-2
doi:

Substances chimiques

Antioxidants 0
Grape Seed Extract 0
Neuroprotective Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

889-907

Références

Prog Neurobiol. 2016 Aug;143:1-35
pubmed: 27283248
Biomed Pharmacother. 2016 Jul;81:242-249
pubmed: 27261600
Microbiol Mol Biol Rev. 2016 Jul 27;80(3):765-77
pubmed: 27466281
J Mol Neurosci. 2014 Dec;54(4):774-9
pubmed: 25022884
Int J Stroke. 2015 Apr;10(3):415-24
pubmed: 25365917
J Clin Invest. 2008 Jan;118(1):133-48
pubmed: 18079966
Phytother Res. 2009 Sep;23(9):1197-204
pubmed: 19140172
Brain Res. 2015 Oct 22;1624:9-18
pubmed: 26220474
Bratisl Lek Listy. 1998 Jul;99(7):386-94
pubmed: 9748729
J Biochem Mol Biol. 2002 Jan 31;35(1):67-86
pubmed: 16248972
J Mol Med (Berl). 2006 May;84(5):349-64
pubmed: 16604332
Cell Rep. 2012 Sep 27;2(3):603-15
pubmed: 22921402
J Nutr Biochem. 2015 Oct;26(10):987-95
pubmed: 26026838
PLoS One. 2014 Jun 24;9(6):e99958
pubmed: 24960035
J Biol Chem. 2015 Jun 5;290(23):14493-503
pubmed: 25882840
J Biol Chem. 2009 May 1;284(18):12447-58
pubmed: 19240038
J Biol Chem. 2003 Feb 21;278(8):5929-40
pubmed: 12488440
Tidsskr Nor Laegeforen. 2005 Jun 2;125(11):1479-81
pubmed: 15940312
J Neurosci. 2004 Sep 1;24(35):7614-22
pubmed: 15342727
Zhonghua Er Ke Za Zhi. 2004 Jun;42(6):441-5
pubmed: 15265432
Biomed Environ Sci. 2015 Apr;28(4):272-80
pubmed: 25966753
Hippocampus. 2010 Jul;20(7):811-9
pubmed: 19623607
Mol Brain. 2014 Mar 27;7:20
pubmed: 24670206
J Neurosci Res. 1999 Jul 15;57(2):255-60
pubmed: 10398303
J Neurochem. 2010 May;113(3):735-48
pubmed: 20141568
Neuroscience. 2013 Dec 3;253:40-54
pubmed: 23988434
Neurosci Res. 2012 May;73(1):1-7
pubmed: 22401840
PLoS One. 2013 Nov 13;8(11):e79982
pubmed: 24236167
Eur J Nutr. 2011 Sep;50(6):401-9
pubmed: 21113812
Neuropharmacology. 2008 Sep;55(3):310-8
pubmed: 18308346
EXCLI J. 2016 Jun 27;15:424-433
pubmed: 27822171
Mol Neurobiol. 2017 Jan;54(1):45-57
pubmed: 26732589
Genome Res. 2003 Nov;13(11):2498-504
pubmed: 14597658
Biomed Pharmacother. 2017 Nov;95:1103-1111
pubmed: 28922729
Curr Med Chem. 2015;22(10):1239-47
pubmed: 25666794
Mol Neurobiol. 2017 May;54(4):2720-2730
pubmed: 27000838
J Neurochem. 2009 Nov;111(4):915-33
pubmed: 19780894
Neurochem Res. 2012 Sep;37(9):2004-13
pubmed: 22684284
Nucleic Acids Res. 2009 Jan;37(1):1-13
pubmed: 19033363
J Clin Neurol. 2014 Apr;10(2):84-93
pubmed: 24829593
Fiziol Zh. 2014;60(5):3-13
pubmed: 25566666
J Biol Chem. 2016 Jun 24;291(26):13608-21
pubmed: 27129213
Cardiovasc Toxicol. 2012 Jun;12(2):158-65
pubmed: 22290400
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2011 Oct;36(10):992-8
pubmed: 22086010
J Cereb Blood Flow Metab. 2002 Mar;22(3):280-8
pubmed: 11891433
Phytother Res. 2008 Jan;22(1):43-8
pubmed: 18165941
Circulation. 2015 Sep 1;132(9):852-72
pubmed: 26195497
Int J Mol Sci. 2015 May 26;16(6):11873-91
pubmed: 26016499
Life Sci. 2000 Jul 7;67(7):821-6
pubmed: 10968411
Can J Physiol Pharmacol. 2013 Dec;91(12):1076-85
pubmed: 24289079
Stroke. 2016 Jan;47(1):187-95
pubmed: 26564104
J Neurosci. 2009 Oct 21;29(42):13242-54
pubmed: 19846712
Prog Neurobiol. 2014 Jan;112:50-69
pubmed: 24157661
Biomed Pharmacother. 2018 Nov;107:534-546
pubmed: 30114637
Toxicology. 2000 Aug 7;148(2-3):187-97
pubmed: 10962138
J Neurochem. 2014 Feb;128(3):419-30
pubmed: 24102330
Physiol Rev. 2007 Jan;87(1):315-424
pubmed: 17237348
Neuron. 2004 Sep 30;44(1):109-20
pubmed: 15450164
Br J Nutr. 2012 Jan;107(1):45-51
pubmed: 21733325

Auteurs

Safwen Kadri (S)

Bioactive Substances Laboratory, Biotechnology Centre, TechnopolisBorj-Cedria, BP-901, 2050, Hammam-Lif, Tunis, Tunisia. kadri_safwen@live.fr.

Mohamed El Ayed (M)

Bioactive Substances Laboratory, Biotechnology Centre, TechnopolisBorj-Cedria, BP-901, 2050, Hammam-Lif, Tunis, Tunisia.

Pascal Cosette (P)

Plateforme Protéomique PISSARO, Institut de Recherche et d'Innovation Biomédicale, Normandie Université, Mont Saint Aignan, France.

Thierry Jouenne (T)

Plateforme Protéomique PISSARO, Institut de Recherche et d'Innovation Biomédicale, Normandie Université, Mont Saint Aignan, France.

Salem Elkhaoui (S)

Bioactive Substances Laboratory, Biotechnology Centre, TechnopolisBorj-Cedria, BP-901, 2050, Hammam-Lif, Tunis, Tunisia.

Sami Zekri (S)

Common Services Unit on Transmission Electron Microscopy, Faculty of Medicineof Tunis, University of Tunis El Manar, Bab Saâdoun, Tunis, Tunisia.

Ferid Limam (F)

Bioactive Substances Laboratory, Biotechnology Centre, TechnopolisBorj-Cedria, BP-901, 2050, Hammam-Lif, Tunis, Tunisia.

Ezzedine Aouani (E)

Bioactive Substances Laboratory, Biotechnology Centre, TechnopolisBorj-Cedria, BP-901, 2050, Hammam-Lif, Tunis, Tunisia.

Meherzia Mokni (M)

Bioactive Substances Laboratory, Biotechnology Centre, TechnopolisBorj-Cedria, BP-901, 2050, Hammam-Lif, Tunis, Tunisia.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH